AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 1-25/75

Authors: BICK RL
Citation: Rl. Bick, STICKY PLATELET SYNDROME - A COMMON-CAUSE OF UNEXPLAINED ARTERIAL ANDVENOUS THROMBOSIS, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 77-81

Authors: BICK RL
Citation: Rl. Bick, UNTITLED, Clinical and applied thrombosis/hemostasis, 4(1), 1998, pp. 1-1

Authors: BICK RL KAPLAN H
Citation: Rl. Bick et H. Kaplan, SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY - CONGENITAL AND ACQUIRED THROMBOPHILIAS, Clinical and applied thrombosis/hemostasis, 4(1), 1998, pp. 25-50

Authors: BICK RL
Citation: Rl. Bick, MAMMEN,EBERHARD,F MD - DEDICATION, The Medical clinics of North America, 82(3), 1998, pp. 3-3

Authors: BICK RL
Citation: Rl. Bick, CURRENT CONCEPTS OF THROMBOSIS - PREVALENT TRENDS FOR DIAGNOSIS AND MANAGEMENT, The Medical clinics of North America, 82(3), 1998, pp. 13-13

Authors: BICK RL KAPLAN H
Citation: Rl. Bick et H. Kaplan, SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY - CONGENITAL AND ACQUIRED CAUSES OF THROMBOSIS, The Medical clinics of North America, 82(3), 1998, pp. 409

Authors: FAREED J CALLAS D HOPPENSTEADT DA WALENGA JM BICK RL
Citation: J. Fareed et al., ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, The Medical clinics of North America, 82(3), 1998, pp. 569

Authors: BICK RL HAAS SK
Citation: Rl. Bick et Sk. Haas, INTERNATIONAL CONSENSUS RECOMMENDATIONS - SUMMARY STATEMENT AND ADDITIONAL SUGGESTED GUIDELINES, The Medical clinics of North America, 82(3), 1998, pp. 613

Authors: WALENGA JM BICK RL
Citation: Jm. Walenga et Rl. Bick, HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE-EFFECTS OF HEPARIN-THERAPY, The Medical clinics of North America, 82(3), 1998, pp. 635

Authors: WEHRMACHER WH MESSMORE HL BICK RL FAREED J
Citation: Wh. Wehrmacher et al., TICLOPIDINE AND CLOPIDOGREL - DO THEY HAVE DIRECT VASCULAR EFFECTS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 225-225

Authors: BICK RL
Citation: Rl. Bick, THE ANTIPHOSPHOLIPID THROMBOSIS SYNDROMES - A COMMON MULTIDISCIPLINARY MEDICAL PROBLEM, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 270-283

Authors: BICK RL
Citation: Rl. Bick, HEPARIN-INDUCED THROMBOCYTOPENIA AND PARADOXICAL THROMBOEMBOLISM - DIAGNOSTIC AND THERAPEUTIC DILEMMAS, Clinical and applied thrombosis/hemostasis, 3(1), 1997, pp. 63-65

Authors: BICK RL
Citation: Rl. Bick, ANTIPHOSPHOLIPID THROMBOSIS SYNDROMES - ETIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND MANAGEMENT, International journal of hematology, 65(3), 1997, pp. 193-213

Authors: BICK RL
Citation: Rl. Bick, HEPARIN-THERAPY AND MONITORING - GUIDELINES AND PRACTICE PARAMETERS FOR CLINICAL AND LABORATORY APPROACHES, Clinical and applied thrombosis/hemostasis, 2, 1996, pp. 12-20

Authors: BICK RL GIRARDI TV LACK WJ COSTA M TITELBAUM D
Citation: Rl. Bick et al., HODGKINS-DISEASE IN ASSOCIATION WITH HEXAVALENT CHROMIUM EXPOSURE, International journal of hematology, 64(3-4), 1996, pp. 257-262

Authors: BICK RL
Citation: Rl. Bick, PARANEOPLASTIC SYNDROMES - PREFACE, Hematology/oncology clinics of North America, 10(4), 1996, pp. 11-11

Authors: FRENKEL EP BICK RL RUTHERFORD CJ
Citation: Ep. Frenkel et al., ANEMIA OF MALIGNANCY, Hematology/oncology clinics of North America, 10(4), 1996, pp. 861

Authors: BICK RL STRAUSS JF FRENKEL EP
Citation: Rl. Bick et al., THROMBOSIS AND HEMORRHAGE IN ONCOLOGY PATIENTS, Hematology/oncology clinics of North America, 10(4), 1996, pp. 875

Authors: BICK RL
Citation: Rl. Bick, DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CLINICAL AND LABORATORY DIAGNOSIS, TREATMENT, AND ASSESSMENT OF THERAPEUTIC RESPONSE, Seminars in thrombosis and hemostasis, 22(1), 1996, pp. 69-88

Authors: BICK RL LAUGHLIN HR COHEN BM STAUB AJ MADDEN T TOOFANIAN A
Citation: Rl. Bick et al., FETAL WASTAGE SYNDROME DUE TO BLOOD PROTEIN PLATELET DEFECTS - RESULTS OF PREVALENCE STUDIES AND TREATMENT OUTCOME WITH LOW-DOSE HEPARIN AND LOW-DOSE ASPIRIN, Clinical and applied thrombosis/hemostasis, 1(4), 1995, pp. 286-292

Authors: BICK RL
Citation: Rl. Bick, EVALUATION OF A NEW HYDROXYETHYL STARCH PREPARATION (HEXTEND(TM)) ON SELECTED COAGULATION PARAMETERS, Clinical and applied thrombosis/hemostasis, 1(3), 1995, pp. 215-229

Authors: BAKER WF BICK RL SCHALE DP SWINYER BP
Citation: Wf. Baker et al., THOROTRAST-INDUCED ANGIOSARCOMA COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION AND MICROANGIOPATHIC HEMOLYTIC-ANEMIA - CASE-REPORT AND REVIEW, Clinical and applied thrombosis/hemostasis, 1(3), 1995, pp. 230-240

Authors: FAREED J BICK RL HOPPENSTEADT DA BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS, Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 87-102

Authors: BICK RL
Citation: Rl. Bick, WHY A NEW JOURNAL ON THROMBOSIS AND HEMOSTASIS, Clinical and applied thrombosis/hemostasis, 1(1), 1995, pp. 1-1

Authors: BICK RL
Citation: Rl. Bick, DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CRITERIA FOR CLINICAL AND LABORATORY DIAGNOSIS AND ASSESSMENT OF THERAPEUTIC RESPONSE, Clinical and applied thrombosis/hemostasis, 1(1), 1995, pp. 3-23
Risultati: 1-25 | 26-50 | 51-75